These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 7634976
21. [Rectal micropolyps after total colectomy in familial polyposis. Efficacy of sulindac]. Charneau J, D'Aubigny N, Burtin P, Person B, Boyer J. Gastroenterol Clin Biol; 1990; 14(2):153-7. PubMed ID: 2158470 [Abstract] [Full Text] [Related]
22. [Role of suindac in the treatment of familial adenomatous polyposis coli]. Landauer S, Halimi C, Caulin C, Bergmann JF. Therapie; 1999; 54(6):675-82. PubMed ID: 10709439 [Abstract] [Full Text] [Related]
23. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Nugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK. Br J Surg; 1993 Dec; 80(12):1618-9. PubMed ID: 8298943 [Abstract] [Full Text] [Related]
25. Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis. Giardiello FM, Casero RA, Hamilton SR, Hylind LM, Trimbath JD, Geiman DE, Judge KR, Hubbard W, Offerhaus GJ, Yang VW. Gastroenterology; 2004 Feb; 126(2):425-31. PubMed ID: 14762779 [Abstract] [Full Text] [Related]
26. Balance between endoscopic and genetic information in the choice of ileorectal anastomosis for familial adenomatous polyposis. Valanzano R, Ficari F, Curia MC, Aceto G, Veschi S, Cama A, Battista P, Tonelli F. J Surg Oncol; 2007 Jan 01; 95(1):28-33. PubMed ID: 17192888 [Abstract] [Full Text] [Related]
27. Sulindac therapy for familial adenomatous polyposis after colectomy and ileorectal anastomosis. Mäkelä JT, Laitinen S. Ann Chir Gynaecol; 1994 Jan 01; 83(3):265-7. PubMed ID: 7857074 [Abstract] [Full Text] [Related]
28. Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac. Keller JJ, Offerhaus GJ, Polak M, Goodman SN, Zahurak ML, Hylind LM, Hamilton SR, Giardiello FM. Gut; 1999 Dec 01; 45(6):822-8. PubMed ID: 10562579 [Abstract] [Full Text] [Related]
29. Residual rectal mucosa after stapled vs. handsewn ileal J-pouch-anal anastomosis in patients with familial adenomatous polyposis coli (FAP)--a critical issue. Ganschow P, Treiber I, Hinz U, Leowardi C, Büchler MW, Kadmon M. Langenbecks Arch Surg; 2015 Feb 01; 400(2):213-9. PubMed ID: 25586093 [Abstract] [Full Text] [Related]
30. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Pasricha PJ, Bedi A, O'Connor K, Rashid A, Akhtar AJ, Zahurak ML, Piantadosi S, Hamilton SR, Giardiello FM. Gastroenterology; 1995 Sep 01; 109(3):994-8. PubMed ID: 7657130 [Abstract] [Full Text] [Related]
31. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients. Sinicrope FA, Half E, Morris JS, Lynch PM, Morrow JD, Levin B, Hawk ET, Cohen DS, Ayers GD, Stephens LC, Familial Adenomatous Polyposis Study Group. Cancer Epidemiol Biomarkers Prev; 2004 Jun 01; 13(6):920-7. PubMed ID: 15184247 [Abstract] [Full Text] [Related]
32. Primary chemoprevention of familial adenomatous polyposis with sulindac. Giardiello FM, Yang VW, Hylind LM, Krush AJ, Petersen GM, Trimbath JD, Piantadosi S, Garrett E, Geiman DE, Hubbard W, Offerhaus GJ, Hamilton SR. N Engl J Med; 2002 Apr 04; 346(14):1054-9. PubMed ID: 11932472 [Abstract] [Full Text] [Related]
33. Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis. Keller JJ, Offerhaus GJ, Drillenburg P, Caspers E, Musler A, Ristimäki A, Giardiello FM. Clin Cancer Res; 2001 Dec 04; 7(12):4000-7. PubMed ID: 11751493 [Abstract] [Full Text] [Related]
34. [Sulindac in familial adenomatous polyposis coli--preliminary findings of a prospective study]. Müller A, Hürlimann R, Meyenberger C, Staub P, Kobler E, Ammann R. Schweiz Med Wochenschr; 1994 Apr 16; 124(15):651-4. PubMed ID: 8191270 [Abstract] [Full Text] [Related]
35. Risk factors for rectal cancer morbidity and mortality in patients with familial adenomatous polyposis after colectomy and ileorectal anastomosis. Björk JA, Akerbrant HI, Iselius LE, Hultcrantz RW. Dis Colon Rectum; 2000 Dec 16; 43(12):1719-25. PubMed ID: 11156457 [Abstract] [Full Text] [Related]
36. Regular endoscopic surveillance and polypectomy is effective in managing rectal adenoma progression following colectomy and ileorectal anastomosis in patients with familial adenomatous polyposis. Anele CC, Xiang J, Martin I, Hawkins M, Man R, Clark SK, Faiz OD, Latchford A. Colorectal Dis; 2022 Mar 16; 24(3):277-283. PubMed ID: 34741380 [Abstract] [Full Text] [Related]
37. Sulindac in familial adenomatous polyposis: evaluation by nuclear morphometry. Fernández-López F, Conde-Freire R, Cadarso-Suárez C, García-Iglesias J, Puente-Domínguez JL, Potel-Lesquereux J. Eur J Surg; 2001 May 16; 167(5):375-81. PubMed ID: 11419555 [Abstract] [Full Text] [Related]
39. [The effects of sulindac on the pathology of colorectal remnant polyps of familial adenomatous polyposis (FAP) patients]. Li J, Lv YM, Jin Z, Cui RL. Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug 18; 37(4):371-3. PubMed ID: 16086054 [Abstract] [Full Text] [Related]
40. Regression of rectal adenomas after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Nicholls RJ, Springall RG, Gallagher P. Br Med J (Clin Res Ed); 1988 Jun 18; 296(6638):1707-8. PubMed ID: 2840998 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]